VJHemOnc is committed to improving our service to you

ASCO 2019 | How to utilize MRD testing for AML

VJHemOnc is committed to improving our service to you

Michael Heuser

In this video, Michael Heuser, MD, of Hannover Medical School, Hanover, Germany, explains the process of how measurable residual disease (MRD) testing can be utilized for acute myeloid leukemia (AML). This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter